TRIALSITEIQ PUBLIC FEASIBILITY SCORECARD · GRADE C

NCT06725030: A Post-market, Real-world Experience: Expanding Access to Care by Incorporating the Symani® Surgical System and Enabling Surgeons

Sponsor: MMI (Medical Microinstruments, Inc.) · Phase: PHASE2 · Area: CARDIOLOGY_METABOLIC · Target Enrollment: 455 pts

Competing Trials Overlap

6 Active Trials

Excess Burn Exposure

$10,624,000

Rescue Site Savings

+$7,005,200

Unlock Full NCT06725030 Backup Super-Site Packet ($49 One-Time Pass)

Download the complete list of top-decile low-cannibalization clinical sites, verified Principal Investigator (PI) direct emails/phones, and protocol optimization benchmarks.

Download $49 NCT06725030 Rescue Dossier →